Pfizer, BioNTech claim their Covid-19 vaccine 90 pc effective in Phase 3 trial
  • 3 years ago
Pfizer Inc and BioNTech SE on Monday said that their Covid-19 vaccine candidate showed 90 per cent effectiveness in Phase 3 trials
Recommended